Armata Pharmaceuticals (ARMP) Preferred Dividend Payments (2013 - 2016)
Armata Pharmaceuticals (ARMP) posted Preferred Dividend Payments of $133000.0 for Q2 2016, down 92.29% sequentially from $1.7 million in Q1 2016, and down 92.72% YoY from $1.8 million in Q3 2015.
Armata Pharmaceuticals (ARMP) Preferred Dividend Payments (2013 - 2016) Analysis & Trends
Armata Pharmaceuticals has reported Preferred Dividend Payments for 4 years, with the latest figure at $133000.0 in Q2 2016.
- Quarterly Preferred Dividend Payments fell 92.72% year-over-year to $133000.0 in Q2 2016, while the trailing twelve-month figure through Dec 2016 was $1.9 million (down 81.92% YoY) and the FY2016 annual result came in at $1.9 million, down 81.92% from the prior year.
- Preferred Dividend Payments fell to $133000.0 in Q2 2016 per ARMP's latest filing, from $1.7 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $7.2 million in Q3 2015 and troughed at $103000.0 in Q2 2013.
- A 4-year average of $1.1 million and a median of $323000.0 in 2014 frame the typical range for Preferred Dividend Payments.
- The sharpest annual moves came in 2015 and 2016: Preferred Dividend Payments surged 2117.65% in 2015, then sank 92.72% in 2016.
- Over 4 years, Preferred Dividend Payments stood at $229000.0 in 2013, then soared by 44.1% to $330000.0 in 2014, then soared by 187.58% to $949000.0 in 2015, then plunged by 85.99% to $133000.0 in 2016.
- According to Business Quant data, Preferred Dividend Payments over the past three periods registered $133000.0, $1.7 million, and $949000.0 for Q2 2016, Q1 2016, and Q4 2015 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 133,000.00 |
| Mar 31, 2016 | 1.73 Mn |
| Dec 31, 2015 | 949,000.00 |
| Sep 30, 2015 | 7.16 Mn |
| Jun 30, 2015 | 1.83 Mn |
| Mar 31, 2015 | 338,000.00 |
| Dec 31, 2014 | 330,000.00 |
| Sep 30, 2014 | 323,000.00 |
| Jun 30, 2014 | 318,000.00 |
| Mar 31, 2014 | 314,000.00 |
| Dec 31, 2013 | 229,000.00 |
| Sep 30, 2013 | 286,000.00 |
| Jun 30, 2013 | 103,000.00 |